MERIDIAN DIAGNOSTICS INC
10-Q/A, EX-27, 2000-08-08
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: MERIDIAN DIAGNOSTICS INC, 10-Q/A, 2000-08-08
Next: MERIDIAN DIAGNOSTICS INC, 10-Q/A, EX-99, 2000-08-08



<TABLE> <S> <C>


<ARTICLE>                     5
<RESTATED>
<MULTIPLIER>                                   1,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                              SEP-30-2000
<PERIOD-START>                                 OCT-01-1999
<PERIOD-END>                                   DEC-31-1999
<CASH>                                         9,031
<SECURITIES>                                   1,003
<RECEIVABLES>                                  12,826
<ALLOWANCES>                                   400
<INVENTORY>                                    10,688
<CURRENT-ASSETS>                               34,709
<PP&E>                                         25,780
<DEPRECIATION>                                 10,687
<TOTAL-ASSETS>                                 75,114
<CURRENT-LIABILITIES>                          12,630
<BONDS>                                        20,000
                          0
                                    0
<COMMON>                                       2,529
<OTHER-SE>                                     31,337
<TOTAL-LIABILITY-AND-EQUITY>                   33,866
<SALES>                                        14,329
<TOTAL-REVENUES>                               14,329
<CGS>                                          5,207
<TOTAL-COSTS>                                  5,207
<OTHER-EXPENSES>                               6,421
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             475
<INCOME-PRETAX>                                2,375
<INCOME-TAX>                                   905
<INCOME-CONTINUING>                            1,470
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   1,470
<EPS-BASIC>                                  0.10
<EPS-DILUTED>                                  0.10


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission